
MDXHEALTH S.A.
Share · BE0974461940 · A3E19Y (XBRU)
No Price
n/a
Current Prices from MDXHEALTH S.A.
Exchange | Ticker | Currency | Last Trade | Price | Daily Change |
---|---|---|---|---|---|
![]() London |
0O8G.L
|
EUR
|
15.12.2023 17:16
|
3,02 EUR
| 0,00 EUR |
Performance
Day | Week | Month | 3 Months | 6 Months | 1 Year | 5 Years |
---|---|---|---|---|---|---|
0,00 % | 0,00 % | - | - | -3,83 % | -3,83 % | -62,72 % |
Company Profile for MDXHEALTH S.A. Share
MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, the Netherlands, Belgium, Spain, Poland, Italy, rest of European Union, and internationally. Its novel prostate cancer genomic testing solutions are SelectMDx, a non-invasive urine test; and ConfirmMDx, an epigenetic test, which provide physicians with a clinical pathway to identify clinically prostate cancer while minimizing the use of invasive procedures that are prone to complications. The company was formerly known as OncoMethylome Sciences SA and changed its name to MDxHealth SA in October 2010. MDxHealth SA was incorporated in 2003 and is headquartered in Herstal, Belgium.
Company Data
Name MDXHEALTH S.A.
Company MDxHealth SA
Website
https://mdxhealth.com
Primary Exchange
Frankfurt

WKN A3E19Y
ISIN BE0974461940
Asset Class Share
Sector Healthcare
Industry Medical - Pharmaceuticals
CEO Mr. Michael K. McGarrity
Market Capitalization 77 Mio
Country Belgium
Currency EUR
Employees 0,3 T
Address CAP Business Center, 4040 Herstal
IPO Date 2008-08-05
Ticker Symbols
Name | Symbol |
---|---|
London | 0O8G.L |
More Shares
Investors who MDXHEALTH S.A. hold also have the following shares in their portfolio:
The financial platform MoneyPeak tracks and analyzes investments and portfolios.
From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.